Tag:
Protox Therapeutics
Latest Headlines
Latest Headlines
Protox lines up $35M for BPH program
Warburg Pincus will invest up to $35 million in Canada's Protox Therapeutics, fueling its new therapy for benign prostatic hyperplasia as it advances into late-stage trials. The investment group will
Protox gets $3M upfront in $75M deal with Kissei
Canada's Protox Therapeutics has landed a $75 million development and commercialization agreement with Japan-based Kissei Pharmaceutical. The $75 million deal covers PRX302, Protox's PSA-activated
